Wait and Scan Management of Intra-canalicular Vestibular Schwannomas: Analysis of Growth and Hearing Outcome. Issue 6 (July 2022)

• Record Type: Journal Article
• Authors: Saleh, Essam; Piccirillo, Enrico; Migliorelli, Andrea; Piroli, Piera; Kihlgren, Caterina; Sanna, Mario
• Is Part Of: Otology & neurotology. Volume 43:Issue 6(2022)
• Page Start: 676
• Page End: 684
• Publication Date: 2022-07
• Subjects: Follow-up -- Hearing loss -- Vestibular schwannoma -- Wait and scan; Otology -- Periodicals; Ear -- Diseases -- Periodicals; Skull base -- Surgery -- Periodicals; 617.8005
• DOI: 10.1097/MAO.0000000000003562
• Languages: English
• ISSNs: 1531-7129

Abstract

Abstract : Objective: To report on the results of intracanalicular vestibular schwannomas (ICVS) that were managed by wait and scan and to analyze the possible predictors of tumor growth and hearing deterioration throughout the observation period. Study Design: A retrospective case series. Setting: Quaternary referral center for skull base pathologies. Patients: Patients with sporadic ICVS managed by wait and scan. Intervention: Serial resonance imaging (MRI) with size measurement and serial audiological evaluation. Main Outcome Measure: Tumor growth defined as 2 mm increase of maximal tumor diameter, further treatment, and hearing preservation either maintain initial modified Sanna hearing class, or maintain initial serviceable hearing (class A/B). Results: 339 patients were enrolled. The mean follow-up was 36.5±31.7 months with a median of 24 months. Tumor growth occurred in 141 patients (40.6%) either as slow growth (SG) in 26.3% of cases or fast growth (FG) in 15.3% of cases. Intervention was performed in only 64 cases (18.8%). Out of 271 patients who underwent hearing analysis, 86 patients (33.5%) showed hearing deterioration to a lower hearing class of the modified Sanna classification. Tumor growth and older age were predictors of hearing deterioration. Of the 125 cases with initial serviceable hearing (Class A/B), 91 cases (72.8%) maintained serviceable hearing at last follow-up. Tumor growth and a worse initial pure tone average (PTA) were predictors of hearing deterioration. Conclusions: Wait and scan management of ICVS is a viable option and only 18.8% of patients needed further treatment. Hearing tends to deteriorate over time.